Waymo opens Ojai robotaxis to select riders as company aims to lower cost of fleet expansion

Alphabet's Waymo is adding new vehicles to its fleet of public robotaxis and is opening up its roomier Ojai vehicles to some ...
The Boston Globe

Cambridge biotech cofounded by Pulitzer winning author and oncologist raises $122 million

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. CREATE Medicines has a new name, an ...
FierceBiotech

Create Medicines fashions $122M fundraise for in vivo CAR-T dreams

As the wave of in vivo CAR-T hype crests, Create Medicines is catching the swell with a $122 million series B meant to back its early pipeline of autoimmune and cancer candidates. Originally launched ...
BioSpace

CREATE Medicines Announces $122 Million Series B Financing to Advance In Vivo CAR Pipeline in Autoimmune Disease and Oncology

CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering in vivo immune programming, today announced the closing of its $122 ...